Tickers

WOLF — Ticker Eval done nvidia/nemotron-3-ultra-550b-a55b:free

Requested 2026-09-21 08:06:28.400511 UTC · finished 2026-09-21 08:16:22.056109 UTC

1. Composite Trajectory Verdict

The income statement, cash flow statement, and balance sheet are all equally critical for WOLF given its capital-intensive semiconductor manufacturing model, high fixed costs, and recent bankruptcy restructuring that reset its capital structure.

Composite Trajectory: Insufficient Data

The current Successor entity (post-September 29, 2025 emergence) has only a single 39-week reporting period (September 30, 2025 to June 28, 2026) with no comparable prior Successor period due to fresh start accounting, which the company explicitly states makes financial statements after September 29, 2025 not comparable to prior periods (10-K 2026-06-28, MD&A Basis of Presentation). The two comparable Predecessor annual periods (FY2024 and FY2025) show significant deterioration in revenue, gross margin, operating loss, and net loss, but they belong to a different reporting entity and cannot be trended with the Successor. Quarterly Successor data from 10-Qs are not available in the provided filings. Therefore, no trend can be established for the current reporting entity.

2. Red Flags

  • Fresh start accounting adopted September 29, 2025 renders all post-emergence financial statements non-comparable with prior periods (10-K 2026-06-28, MD&A Basis of Presentation).
  • Successor period (39 weeks) reported a net loss of $415.8M on revenue of $468.3M, with a gross loss of $155.0M (33.1% of revenue) (10-K 2026-06-28, Consolidated Statements of Operations).
  • Predecessor FY2025 net loss from continuing operations widened to $1,609.2M from $573.6M in FY2024, with revenue declining 6.1% to $757.6M and gross margin collapsing from +9.6% to -16.1% (10-K 2026-06-28, Consolidated Statements of Operations).
  • Cash used in operating activities remained deeply negative: $711.7M in FY2025 (Predecessor) and $180.8M in the 39-week Successor period (10-K 2026-06-28, Consolidated Statements of Cash Flows).
  • Inventory write-offs of $34.0M in Successor period and $29.0M in Predecessor period indicate persistent obsolescence issues (10-K 2026-06-28, Note 2 Inventories).
  • Goodwill impairment of $359.2M and restructuring charges of $417.6M in FY2025 (10-K 2026-06-28, Consolidated Statements of Operations).
  • Minimum cash requirement of $350M under New Senior Secured Notes (10-K 2026-06-28, Note 2 Liquidity).
  • Total liabilities reduced from $7,301.5M (Predecessor) to $2,074.7M (Successor) but not comparable due to reorganization (10-K 2026-06-28, Consolidated Balance Sheets).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Insufficient Data

Overall Assessment: The Successor entity has only one 39-week reporting period (September 30, 2025 to June 28, 2026) with revenue of $468.3M, gross loss of $155.0M, operating loss of $388.0M, and net loss of $415.8M (10-K 2026-06-28, Consolidated Statements of Operations). No prior Successor period exists for comparison due to fresh start accounting adopted September 29, 2025. The two comparable Predecessor annual periods (FY2024 and FY2025) show a sharp deterioration—revenue fell from $807.2M to $757.6M, gross profit swung from +$77.4M to -$121.6M, and net loss from continuing operations widened from $573.6M to $1,609.2M—but these results belong to a different reporting entity and cannot be combined with the Successor period to form a trend (10-K 2026-06-28, Consolidated Statements of Operations). Quarterly Successor earnings data from 10-Qs are not provided in the filings.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Insufficient Data

Overall Assessment: The Successor period (39 weeks) used $180.8M in operating cash flow, while the Predecessor FY2025 used $711.7M and FY2024 used $725.6M (including discontinued operations) (10-K 2026-06-28, Consolidated Statements of Cash Flows). Investing cash flow was positive $530.7M in the Successor period due to $733.2M in government incentive receipts, versus negative $268.1M in FY2025 and negative $1,943.3M in FY2024 (10-K 2026-06-28, Consolidated Statements of Cash Flows). Financing cash flow was negative $254.0M in the Successor period, positive $400.1M in FY2025, and positive $1,958.0M in FY2024 (10-K 2026-06-28, Consolidated Statements of Cash Flows). Because the Successor period is not comparable to Predecessor periods and only one Successor period is available, no cash flow trend can be established for the current entity.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Insufficient Data

Overall Assessment: The Successor balance sheet at June 28, 2026 shows total assets of $3,004.9M, total liabilities of $2,074.7M, and stockholders' equity of $930.2M (10-K 2026-06-28, Consolidated Balance Sheets). The Predecessor balance sheet at June 29, 2025 shows total assets of $6,854.4M, total liabilities of $7,301.5M, and a stockholders' deficit of $447.1M (10-K 2026-06-28, Consolidated Balance Sheets). The company explicitly states these are not comparable due to fresh start accounting and the Chapter 11 reorganization (10-K 2026-06-28, MD&A Basis of Presentation). No prior Successor balance sheet exists. Key Successor balance sheet items include cash and short-term investments of $1,088.6M, inventories of $234.2M, property and equipment of $691.4M, intangible assets of $392.2M (largely from fresh start), long-term debt of $931.0M, and convertible notes of $756.5M (10-K 2026-06-28, Consolidated Balance Sheets). Without a comparable prior Successor balance sheet, no trend can be assessed.

6. Data Gaps

  • Comparable prior Successor period (annual or quarterly) for income statement, cash flow, and balance sheet trend analysis.
  • Quarterly Successor periods (Q1, Q2, Q3 FY2026) from 10-Qs (periods 2025-09-28, 2025-12-28, 2026-03-29) — content not provided in filings.
  • Full fiscal year 2026 Successor results (52-week period) — only 39 weeks reported.
  • Segment-level revenue and margin trends (company reports one segment).
  • Non-GAAP metrics referenced in MD&A (e.g., adjusted EBITDA) not provided in GAAP financial statements.
  • Detailed debt maturity schedule beyond minimum cash requirement.
  • Working capital trends (accounts receivable, inventory, accounts payable) on a comparable basis.
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status